4-甲基-2-苯基乙炔基-吡啶 | 63731-33-9

• 物质功能分类: 医药中间体
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 4-甲基-2-苯基乙炔基-吡啶
• 英文名称: 4-methyl-2-phenylethynyl-pyridine
• 英文别名: 4-Methyl-2-phenylaethinyl-pyridin；4-methyl-2-phenylethynylpyridine；4-Methyl-2-(phenylethynyl)pyridine；4-methyl-2-(2-phenylethynyl)pyridine
• CAS: 63731-33-9
• 化学式: C₁₄H₁₁N
• 分子量: 193.248
• InChiKey: KYNCWWUJOAPSAP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-甲基-2-苯基乙炔基-吡啶 在 钯 氢气 作用下， 以 甲醇 为溶剂， 反应 20.0h， 生成 methyl-4 (phenyl-2 ethyl)-2 pyridine
  参考文献：
  名称：

  Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use

  摘要：

  本发明涉及由式(I)定义的化合物，其中A，B，X，m，n和o的基团如权利要求1中所定义，具有有价值的药理活性。特别地，这些化合物是11β-羟基类固醇脱氢酶（HSD）1的抑制剂，因此适用于治疗和预防可以通过抑制该酶而受到影响的疾病，如代谢性疾病，特别是2型糖尿病，肥胖症和血脂异常。

  公开号：

  US20110028445A1
• 作为产物：
  描述：

  2-(α,β-dibromo-phenethyl)-4-methyl-pyridine 生成 4-甲基-2-苯基乙炔基-吡啶
  参考文献：
  名称：

  Clemo et al., Journal of the Chemical Society, 1950, p. 1140

  摘要：

  DOI：

文献信息

• Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
  申请人：Peters Stefan

  公开号：US20110269791A1

  公开（公告）日：2011-11-03

  The present invention relates to compounds defined by Formula (I), wherein the groups A, B, X, m, n and o are defined as in claim 1, possessing valuable pharmacological activity. Particularly the compounds are inhibitors of 11β-hydroxysteroid dehydrogenase (HSD) 1 and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme, such as metabolic diseases, in particular diabetes type 2, obesity and dyslipidemia.

  本发明涉及由式（I）定义的化合物，其中A、B、X、m、n和o基团的定义如权利要求1中所述，具有有价值的药理活性。特别是这些化合物是11β-羟基类固醇脱氢酶（HSD）1的抑制剂，因此适用于治疗和预防可以受到该酶抑制影响的疾病，如代谢性疾病，特别是2型糖尿病、肥胖症和血脂异常。
• Spin Frustrated Double Chain {[Fe(PZDA)H₂O)₂]·2H₂O}_n(H₂PZDA=2,3-Pyrazinedicarboxylic Acid)
  作者：Song Gao、Bao-Qing Ma、Tao Yi、Zhe-Ming Wang、Chun-Sheng Liao、Chun-Hua Yan、Guang-Xian Xu

  DOI：10.1246/cl.1999.773

  日期：1999.8

  A novel compound [Fe(PZDA)(H2O)2]·2H2O}n has been synthesized and its structure determined by X-ray diffraction analysis, which consists of a quasi-ladder-like double chain running along a axis where Fe(II) ions are linked through the carboxylic groups acting as the edges of the ladder and pyrazine rings functioning as the rungs. Variable-temperature magnetic susceptibility study indicates the presence of spin frustration in the double chain compound.

  合成了一种新化合物 [Fe(PZDA)(H2O)2]·2 }n，并通过 X 射线衍射分析确定了其结构。该化合物由沿 a 轴的准梯形双链构成，其中 Fe(II) 离子通过羧基相连，羧基作为梯子的边缘，而吡嗪环则作为梯子的横档。变温磁 susceptibili 研究表明，该双链化合物存在自旋挫折现象。
• Novel synthesis of indolizines
  作者：Nagatoshi Nishiwaki、Kiyonori Furuta、Mitsuo Komatsu、Yoshiki Ohshiro

  DOI：10.1039/c39900001151

  日期：——

  2-Phenylethnylpyridine reacted with dimethyl acetylenedicarboxylate (DMAD) in the presence of a proton source such as an alcohol to give Indolizines having methoxycarbonyl groups at the 2- or 2,3-positions in high yields.

  2-苯乙炔基吡啶与乙炔二羧酸二甲酯（DMAD）在质子源（例如醇）存在下反应，以高收率得到在2-或2,3-位具有甲氧羰基的吲哚嗪。
• Aryl-and Heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
  申请人：Himmelsbach Frank

  公开号：US20110190262A1

  公开（公告）日：2011-08-04

  The present invention relates to compounds defined by formula I wherein the groups R 1 to R 3 , X, m, n and o are defined as in claim 1 , possessing valuable pharmacological activity. Particularly the compounds are inhibitors of 11β-hydroxysteroid dehydrogenase (HSD) 1 and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme, such as metabolic diseases, in particular diabetes type 2, obesity and dyslipidemia.

  本发明涉及公式I所定义的化合物，其中R1至R3、X、m、n和o的定义如权利要求书中所述，具有有价值的药理活性。特别地，这些化合物是11β-羟基类固醇脱氢酶（HSD）1的抑制剂，因此适用于治疗和预防可以通过抑制该酶而受影响的疾病，如代谢性疾病，特别是2型糖尿病、肥胖症和血脂异常。
• Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
  申请人：Himmelsbach Frank

  公开号：US08859580B2

  公开（公告）日：2014-10-14

  The present invention relates to compounds defined by formula I wherein the groups R1 to R3, X, m, n and o are defined as in claim 1, possessing valuable pharmacological activity. Particularly the compounds are inhibitors of 11β-hydroxysteroid dehydrogenase (HSD) 1 and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme, such as metabolic diseases, in particular diabetes type 2, obesity and dyslipidemia.

  本发明涉及公式I定义的化合物，其中R1至R3、X、m、n和o组的定义如权利要求书中所述，具有有价值的药理活性。特别地，这些化合物是11β-羟基类固醇脱氢酶（HSD）1的抑制剂，因此适用于治疗和预防可以受到该酶抑制影响的疾病，例如代谢性疾病，特别是2型糖尿病、肥胖症和血脂异常。